MedPath
HSA Approval

ACUSTOP CATAPLASMA PLASTER 40 mg/sheet

SIN12090P

ACUSTOP CATAPLASMA PLASTER 40 mg/sheet

ACUSTOP CATAPLASMA PLASTER 40 mg/sheet

September 30, 2002

EMERGING PHARMA (S) PTE LTD

EMERGING PHARMA (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEMERGING PHARMA (S) PTE LTD
Licence HolderEMERGING PHARMA (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

PATCH

**\[Dosage & administration\]** Apply 1 sheet of Acustop to the affected area twice a day.

TRANSDERMAL

Medical Information

**\[Indication\]** Acustop is used to relieve pain and swelling in a number of painful conditions affecting the joints, muscle and tendon. Acustop relieves rheumatic and muscular pain, and reduces swelling and inflammation such as arthritis, painful shoulder syndrome, inflammation of tendon and sheath that surrounds the tendon. Acustop is also indicated for tennis elbow, sore muscle and pain resulting from trauma.

Under **\[Precautions & side effects\]** 1\. Do not apply to the patients of the followings 1. Patients with history of hypersensitivity to this drug. 2. Patients with aspirin induced asthma (nonsteroidal anti-inflammatory drug induced asthma) or with history of it.

M02AA19

flurbiprofen

Manufacturer Information

EMERGING PHARMA (S) PTE LTD

GC BIOPHARMA CORP.

Active Ingredients

FLURBIPROFEN

40 mg/sheet

Flurbiprofen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACUSTOP CATAPLASMA PLASTER 40 mg/sheet - HSA Approval | MedPath